Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 3Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Dermatologic 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Breast Neoplasms 1256Neoplasms 1074Carcinoma, Non-Small-Cell Lung 874Prostatic Neoplasms 714Lung Neoplasms 596Colorectal Neoplasms 590Neoplasm Metastasis 452Multiple Myeloma 432Leukemia, Myeloid, Acute 423Pancreatic Neoplasms 370Ovarian Neoplasms 367Melanoma 324Carcinoma, Hepatocellular 299Squamous Cell Carcinoma of Head and Neck 276Brain Neoplasms 275Recurrence 273Stomach Neoplasms 245Head and Neck Neoplasms 241Glioblastoma 239Carcinoma, Renal Cell 227Lymphoma 226Triple Negative Breast Neoplasms 225Precursor Cell Lymphoblastic Leukemia-Lymphoma 222Hematologic Neoplasms 212Urinary Bladder Neoplasms 211Uterine Cervical Neoplasms 200Endometrial Neoplasms 199Sarcoma 195Glioma 194Lymphoma, Non-Hodgkin 188

Interventions

Tape Recording 1Opdualag 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Patient Preference × 90 days × Clear all
NCT04925154 2026-05-14

Pathos

Sir Mortimer B. Davis - Jewish General Hospital

Recruiting
192 enrolled
Gastrointestinal

Colorectal Neoplasms, Patient Preference

NCT06125795 2026-05-01

PROVIDENCE

AbbVie

Active not recruiting
146 enrolled
LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Patient Preference

NCT05377957 2026-04-15

PROQEM

Leiden University Medical Center

Active not recruiting
500 enrolled
Dermatologic

Uveal Melanoma, Patient Preference

NCT06101134 2026-04-09

A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Bristol-Myers Squibb

Phase 2 Active not recruiting
100 enrolled 11 charts
Dermatologic

Melanoma, Neoplasm Metastasis, Patient Preference

NCT07483905 2026-03-19

CHeMoON

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting
200 enrolled

Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡